File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Book Chapter: Systemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-targeted Anti-angiogenic Inhibitors
  • Basic View
  • Metadata View
  • XML View
TitleSystemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-targeted Anti-angiogenic Inhibitors
 
AuthorsChiu, JW
Pang, RWC
Poon, RTP
Yau, T
 
Issue Date2011
 
PublisherInTech
 
CitationSystemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-targeted Anti-angiogenic Inhibitors. In Lau, JWY (Ed.), Hepatocellular Carcinoma: Clinical Research, p. 309-320. Rijeka, Croatia: InTech, 2011 [How to Cite?]
DOI: http://dx.doi.org/10.5772/27152
 
ISBN9789535101123
 
DOIhttp://dx.doi.org/10.5772/27152
 
DC FieldValue
dc.contributor.authorChiu, JW
 
dc.contributor.authorPang, RWC
 
dc.contributor.authorPoon, RTP
 
dc.contributor.authorYau, T
 
dc.date.accessioned2012-09-20T08:41:44Z
 
dc.date.available2012-09-20T08:41:44Z
 
dc.date.issued2011
 
dc.description.naturelink_to_OA_fulltext
 
dc.identifier.citationSystemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-targeted Anti-angiogenic Inhibitors. In Lau, JWY (Ed.), Hepatocellular Carcinoma: Clinical Research, p. 309-320. Rijeka, Croatia: InTech, 2011 [How to Cite?]
DOI: http://dx.doi.org/10.5772/27152
 
dc.identifier.doihttp://dx.doi.org/10.5772/27152
 
dc.identifier.epage320
 
dc.identifier.hkuros209088
 
dc.identifier.isbn9789535101123
 
dc.identifier.spage309
 
dc.identifier.urihttp://hdl.handle.net/10722/166592
 
dc.languageeng
 
dc.publisherInTech
 
dc.publisher.placeRijeka, Croatia
 
dc.relation.ispartofHepatocellular Carcinoma: Clinical Research
 
dc.titleSystemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-targeted Anti-angiogenic Inhibitors
 
dc.typeBook_Chapter
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Chiu, JW</contributor.author>
<contributor.author>Pang, RWC</contributor.author>
<contributor.author>Poon, RTP</contributor.author>
<contributor.author>Yau, T</contributor.author>
<date.accessioned>2012-09-20T08:41:44Z</date.accessioned>
<date.available>2012-09-20T08:41:44Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>Systemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-targeted Anti-angiogenic Inhibitors. In Lau, JWY (Ed.), Hepatocellular Carcinoma: Clinical Research, p. 309-320. Rijeka, Croatia: InTech, 2011</identifier.citation>
<identifier.isbn>9789535101123</identifier.isbn>
<identifier.uri>http://hdl.handle.net/10722/166592</identifier.uri>
<language>eng</language>
<publisher>InTech</publisher>
<relation.ispartof>Hepatocellular Carcinoma: Clinical Research</relation.ispartof>
<title>Systemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-targeted Anti-angiogenic Inhibitors</title>
<type>Book_Chapter</type>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.doi>10.5772/27152</identifier.doi>
<identifier.hkuros>209088</identifier.hkuros>
<identifier.spage>309</identifier.spage>
<identifier.epage>320</identifier.epage>
<publisher.place>Rijeka, Croatia</publisher.place>
<bitstream.url>http://hub.hku.hk/bitstream/10722/166592/1/re01.htm</bitstream.url>
</item>